Nepal’s Department of Drug Administration has suspended the sale and distribution of Biotax 1gm, an antibiotic injection produced by an Indian company, due to ‘significant health concerns’, according to a report by Nepal’s national daily The Kathmandu Post.
Nepal’s drug regulatory authority mentions laboratory tests on batch F300460 of ‘Biotax 1gm’, manufactured by Ahmedabad-based Zydus Healthcare Limited, indicating non-compliance with production standards.
